Alan Bryer

3.5k total citations · 1 hit paper
45 papers, 2.2k citations indexed

About

Alan Bryer is a scholar working on Epidemiology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Alan Bryer has authored 45 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 12 papers in Cellular and Molecular Neuroscience and 11 papers in Molecular Biology. Recurrent topics in Alan Bryer's work include Genetic Neurodegenerative Diseases (12 papers), Acute Ischemic Stroke Management (12 papers) and Mitochondrial Function and Pathology (10 papers). Alan Bryer is often cited by papers focused on Genetic Neurodegenerative Diseases (12 papers), Acute Ischemic Stroke Management (12 papers) and Mitochondrial Function and Pathology (10 papers). Alan Bryer collaborates with scholars based in South Africa, United Kingdom and Malawi. Alan Bryer's co-authors include Lawrence J. Schut, S. H. Subramony, Myles Connor, Paula Coutinho, Norbert Nighoghossian, K. Wessel, Hans‐Christoph Diener, M. Ben Hamida, Alessandro Filla and Mark Hallett and has published in prestigious journals such as The Lancet, Neurology and Stroke.

In The Last Decade

Alan Bryer

44 papers receiving 2.2k citations

Hit Papers

International Cooperative Ataxia Rating Scale for pharmac... 1997 2026 2006 2016 1997 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Bryer South Africa 19 837 640 551 398 345 45 2.2k
Yuen T. So United States 29 477 0.6× 190 0.3× 1.2k 2.1× 333 0.8× 132 0.4× 65 3.4k
Zoë Fox United Kingdom 27 450 0.5× 367 0.6× 1.2k 2.2× 897 2.3× 156 0.5× 55 2.7k
R J Guiloff United Kingdom 23 384 0.5× 241 0.4× 852 1.5× 283 0.7× 83 0.2× 74 2.1k
Richard K. Olney United States 36 1.0k 1.2× 351 0.5× 2.5k 4.5× 229 0.6× 80 0.2× 65 3.9k
Christian Eggers Germany 27 187 0.2× 348 0.5× 281 0.5× 327 0.8× 179 0.5× 81 2.4k
Y. So United States 18 466 0.6× 160 0.3× 1.3k 2.4× 147 0.4× 90 0.3× 23 2.5k
Vicki M. Soukup United States 17 165 0.2× 128 0.2× 252 0.5× 190 0.5× 221 0.6× 21 1.4k
C M Mehringer United States 31 330 0.4× 234 0.4× 1.1k 2.0× 421 1.1× 51 0.1× 68 3.4k
George Lantos United States 23 186 0.2× 94 0.1× 531 1.0× 316 0.8× 152 0.4× 38 1.7k
Sophie Tézenas du Montcel France 34 1.5k 1.8× 631 1.0× 2.7k 4.9× 240 0.6× 80 0.2× 137 4.9k

Countries citing papers authored by Alan Bryer

Since Specialization
Citations

This map shows the geographic impact of Alan Bryer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Bryer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Bryer more than expected).

Fields of papers citing papers by Alan Bryer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Bryer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Bryer. The network helps show where Alan Bryer may publish in the future.

Co-authorship network of co-authors of Alan Bryer

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Bryer. A scholar is included among the top collaborators of Alan Bryer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Bryer. Alan Bryer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marais, Gert, et al.. (2022). Varicella‐zoster virus reactivation is frequently detected in HIV‐infected individuals presenting with stroke. Journal of Medical Virology. 94(6). 2675–2683. 11 indexed citations
2.
Bateman, Kathleen, et al.. (2021). Viral protein R polymorphisms in the pathogenesis of HIV-associated acute ischaemic stroke: a case–control study. Journal of NeuroVirology. 27(1). 137–144. 6 indexed citations
3.
London, Leslie, et al.. (2021). Shortfall in stroke care: A study of ischaemic stroke care practices in a South African metropole. South African Medical Journal. 111(3). 215–215. 5 indexed citations
4.
Rayner, Brian, et al.. (2019). Registration of amiloride in South Africa: Cutting the Gordian knot. South African Medical Journal. 109(9). 632–632. 2 indexed citations
5.
Bryer, Alan, et al.. (2018). Poor anticoagulation control in patients taking warfarin at a tertiary and district-level prothrombin clinic in Cape Town, South Africa. South African Medical Journal. 108(6). 490–490. 24 indexed citations
6.
Greenberg, Leslie S., et al.. (2016). The hereditary ataxias: Where are we now? Four decades of local research. South African Medical Journal. 106(6). 38–38. 7 indexed citations
7.
Bateman, Kathleen, et al.. (2014). Thrombolysis risk prediction : applying the SITS-SICH and SEDAN scores in South African patients : cardiovascular topic. Cardiovascular journal of South Africa. 25(5). 224–227. 4 indexed citations
8.
Bryer, Alan, et al.. (2012). Inherited polyglutamine spinocerebellar ataxias in South Africa. South African Medical Journal. 102(8). 683–683. 21 indexed citations
9.
Wasserman, Sean & Alan Bryer. (2012). Early outcomes of thrombolysis for acute ischaemic stroke in a South African tertiary care centre. South African Medical Journal. 102(6). 541–541. 8 indexed citations
10.
Wasserman, Sean, et al.. (2011). The great pretender. The Lancet. 377(9781). 1976–1976. 6 indexed citations
11.
Villiers, Linda de, Motasim Badri, Mónica Ferreira, & Alan Bryer. (2011). Stroke outcomes in a socio-economically disadvantaged urban community. South African Medical Journal. 101(5). 345–345. 26 indexed citations
12.
Wasserman, Sean, Linda de Villiers, & Alan Bryer. (2009). Community-based care of stroke patients in a rural African setting.. PubMed. 99(8). 579–83. 47 indexed citations
13.
Bryer, Alan. (2008). 'Time is brain' and stroke units : stroke care today : editorial. 5(4). 151–153. 1 indexed citations
14.
Tipping, Brent, Linda de Villiers, Helen Wainwright, Sally Candy, & Alan Bryer. (2007). Stroke in patients with human immunodeficiency virus infection. Journal of Neurology Neurosurgery & Psychiatry. 78(12). 1320–1324. 123 indexed citations
15.
Bryer, Alan, Amanda Krause, P.L.A. Bill, et al.. (2003). The hereditary adult-onset ataxias in South Africa. Journal of the Neurological Sciences. 216(1). 47–54. 64 indexed citations
16.
Bryer, Alan, et al.. (2001). When is it not Huntington's disease?. PubMed. 91(2). 132–3. 1 indexed citations
17.
Trouillas, P, T Takayanagi, Mark Hallett, et al.. (1997). International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. Journal of the Neurological Sciences. 145(2). 205–211. 1010 indexed citations breakdown →
18.
Bryer, Alan, et al.. (1997). The sword of Damocles: The psychosocial impact of familial spinocerebellar ataxia in South Africa. American Journal of Medical Genetics. 74(3). 270–274. 4 indexed citations
19.
Ramesar, Raj, Soraya Bardien, Peter Beighton, & Alan Bryer. (1997). Expanded CAG repeats in spinocerebellar ataxia (SCA1) segregate with distinct haplotypes in South African families. Human Genetics. 100(1). 131–137. 18 indexed citations
20.
Ranum, Laura P.W., Ming‐Yi Chung, Sandro Banfi, et al.. (1994). Molecular and clinical correlations in spinocerebellar ataxia type I: evidence for familial effects on the age at onset.. PubMed. 55(2). 244–52. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026